Trump pushes revised healthcare bill, saying, “The plan gets better and better;” well, not really






The News: President Donald Trump, when asked last week whether he would choose to either push an Obamacare repeal bill or government funding measure through Congress this week, said he… Read more »

Novartis teams up with Allergan in NASH gamble; heated race to riches in full swing






The News: Allergan PLC (Dublin IRL) is expanding its research and development program on non-alcoholic steatohepatitis (NASH) through a collaboration with Novartis AG (Basel CHE) that will test a new… Read more »

UnitedHealth crushes 1Q estimates post Obamacare dump; first to jettison social conscience now taking leadership role






The News: UnitedHealth Group Inc. (Minnetonka MN) posted stronger-than-expected earnings Tuesday (April 18, 2017) in the first quarter without the vast majority of its Affordable Care Act-compatible individual health-insurance business. The… Read more »

Healthcare stocks have rough week as TherapeuticsMD, NantHealth fall flat; but Neurocrine, Tocagen shine






TherapeuticsMD Inc.(NYSE: TXMD) led a large contingent of stocks performing faceplants among the healthcare ranks. The clinical-stage biotech company focused on women’s health, plummeted $2.19, or 28%, to $7.70 in… Read more »

OncoMed rocked by combo punch as cancer trial bombs and Bayer walks; CEO not about to raise white flag






The News: OncoMed Pharmaceuticals Inc. (Redwood City CA) began the week with a combination punch that some say spells a knockout in the near future. In back-to-back statements, OncoMed revealed… Read more »

Wall Street cheers as Axovant snags biotech star David Hung; failed Alzheimer’s drug not impressed






The News: Axovant Sciences Ltd. (Hamilton Bermuda) announced that former Medivation Inc. (San Francisco) chief executive and founder David Hung has been selected as its next CEO effective April 7, 2017 sending… Read more »

Rather than imploding per Pres. Trump, Obamacare actually stabilizing per S&P report; who to believe






The News: The Obamacare markets are stabilizing for insurers, said a report released by Standard & Poor’s Financial Services LLC (NYC), but that could change if lawmakers choose to alter… Read more »

Week’s opening stock roundup: gainers include Novocure, Steadymed; but Corvus, NewLink rocked






Here to start your trading week are the major movers from last week and where they stand this morning: Novocure (Nasdaq: NVCR) led advancing issues, soaring $3.25, or 40% over the… Read more »

Message to GOP on Trumpcare resuscitation effort: it’s dead; get over it






The News: House Speaker Paul Ryan announced a Republican agreement Thursday (April 6, 2017) on legislative language that he said will bring the chamber closer to passing a bill to… Read more »

Mylan’s EpiPen profitable despite recalls, lawsuits; stock price immune to ethics rants






Mylan NV (Amsterdam) is facing a new class-action lawsuit related to the price hikes of it EpiPen devices. The lawsuit was filed in federal court in Tacoma, Washington on Monday… Read more »